These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 3771430

  • 1. Emergence of transferable amikacin resistance in enterobacteria in a Czechoslovakian clinic.
    Krcméry V, Havlik J.
    J Antimicrob Chemother; 1986 Sep; 18(3):429-31. PubMed ID: 3771430
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of transferable amikacin resistance in enterobacteria in a Czechoslovak clinic.
    Kettner M, Macicková T, Navarová J, Krcméry V, Havlík J.
    J Antimicrob Chemother; 1988 Jul; 22(1):82-4. PubMed ID: 3170394
    [No Abstract] [Full Text] [Related]

  • 3. [Amikacin resistance transfer in Enterobacteriaceae isolated at various departments of the Medical School Hospital].
    Krcméry V, Antal M, Gabrielová A, Havlík J.
    Cesk Pediatr; 1987 Jun; 42(6):370-1. PubMed ID: 3664751
    [No Abstract] [Full Text] [Related]

  • 4. [Molecular characterization of the transferable resistance to amikacin in Enterobacteriaceae strains isolated from hospital infections].
    Martínez MA, Pinto ME.
    Rev Med Chil; 1993 Sep; 121(9):969-74. PubMed ID: 8191162
    [Abstract] [Full Text] [Related]

  • 5. Transferable amikacin resistance in gram-negative bacterial isolates.
    Kallová J, Macicková T, Majtánová A, Aghová A, Adam D, Kettner M.
    Chemotherapy; 1995 Sep; 41(3):187-92. PubMed ID: 7656664
    [Abstract] [Full Text] [Related]

  • 6. [Amikacin resistance of clinical strains of Enterobacteriaceae and Pseudomonas].
    Moreva TV, Anisimova LA, Erova TE, Boronin AM.
    Antibiot Khimioter; 1992 Apr; 37(4):25-8. PubMed ID: 1417311
    [Abstract] [Full Text] [Related]

  • 7. Amikacin resistance: transfers in Pseudomonas aeruginosa and Enterobacteriaceae.
    Lebek G, Výmola F, Kettner M, Krcméry V, Antal M, Knothe H, Mitsuhashi S.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Apr; 249(4):557-9. PubMed ID: 6797152
    [No Abstract] [Full Text] [Related]

  • 8. Transferable amikacin and cefamandole resistance: Pseudomonas maltophilia and Acinetobacter strains as possible reservoirs of R plasmids.
    Krcméry V, Langsádl L, Antal M, Seckárová A.
    J Hyg Epidemiol Microbiol Immunol; 1985 Apr; 29(2):141-6. PubMed ID: 3926873
    [Abstract] [Full Text] [Related]

  • 9. [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
    Ronco E, Migueres ML, Vacheron F, Guenounou M.
    Pathol Biol (Paris); 1988 May; 36(5):430-4. PubMed ID: 3043339
    [Abstract] [Full Text] [Related]

  • 10. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
    Al-Asadi MJ, Towner K, Greenwood D.
    J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
    [Abstract] [Full Text] [Related]

  • 11. Analysis of neomycin, kanamycin, tobramycin and amikacin resistance mechanisms in gentamicin-resistant isolates of Enterobacteriaceae.
    Adwan K, Abu-Hasan N, Al-Asmar H.
    J Med Microbiol; 1998 Nov; 47(11):1019-21. PubMed ID: 9822302
    [Abstract] [Full Text] [Related]

  • 12. [A three-dimensional model for in vitro study of the association of three antibiotics. Application to the activity of piperacillin, tazobactam and amikacin against five strains of enterobacteria as a function of their phenotype of beta-lactam resistance].
    Duez JM, Cordin X, Siebor E, Pechinot A, Chamard-Neuwirth C, Kazmierczak A.
    Pathol Biol (Paris); 1998 Jan; 46(1):67-72. PubMed ID: 9769939
    [Abstract] [Full Text] [Related]

  • 13. [Phenotypes of resistance to aminosides and sensitivity of amikacin in hospitals].
    Witchitz JL, Golstein FW, Pangon B, Christol D, Acar JF.
    Nouv Presse Med; 1979 Oct 31; 8(42):3417-20. PubMed ID: 537886
    [No Abstract] [Full Text] [Related]

  • 14. [Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin].
    Kazmierczak A, Gailliard MC, Pothier P, Siebor E, Portier H.
    Nouv Presse Med; 1979 Oct 31; 8(42):3399-402. PubMed ID: 537884
    [No Abstract] [Full Text] [Related]

  • 15. Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae.
    Tselentis J, Legakis NJ, Nicolas KJ, Melissinos K, Papavassiliou J.
    Chemotherapy; 1980 Oct 31; 26(6):409-17. PubMed ID: 7408554
    [Abstract] [Full Text] [Related]

  • 16. Activity of cefotaxime and amikacin against 14,272 gram-negative bacteria from clinical samples in the period 1980 to 1985.
    Dámaso D, Sánchez-Moreno MP, Martínez-Martínez L, Mesa E, Portero F, Mendaza P, Daza RM.
    Drugs; 1988 Oct 31; 35 Suppl 2():1-5. PubMed ID: 3396470
    [Abstract] [Full Text] [Related]

  • 17. [Possible errors in the interpretation of bacterial sensitivity to aminoglycoside antibiotics].
    García Hierro P, Ponte Miramontes MC, Soriano García F.
    Rev Clin Esp; 1980 Oct 31; 159(2):87-90. PubMed ID: 7209044
    [No Abstract] [Full Text] [Related]

  • 18. Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.
    Acar JF, Witchitz JL, Goldstein F, Talbot JN, Le Goffic F.
    J Infect Dis; 1976 Nov 31; 134 SUPPL():S280-5. PubMed ID: 825587
    [Abstract] [Full Text] [Related]

  • 19. Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use.
    Levine JF, Maslow MJ, Leibowitz RE, Pollock AA, Hanna BA, Schaefler S, Simberkoff MS, Rahal JJ.
    J Infect Dis; 1985 Feb 31; 151(2):295-300. PubMed ID: 3918124
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.